Arcturus Therapeutics has been doing great, which can be seen in the way its stock has been behaving. Considering that analysts are in agreement that the company's stock will go up by a minimum of 50 percent in the next twelve months, I don't see a reason not to buy.
1 reply
I agree. I just added it to my portfolio.